tirzepatide kidney disease SURPASS-4: slows in adults with type 2 diabetes, CV risk Not currently a kidney therapy.

[72][73][74][75] Unfortunately in spite of all the potentially beneficial effects of GLP-1 on glucose homeostasis, the therapeutic potential of naturally occurring GLP-1 is limited, due to its extremely short half-life of less than 2 minutes largely due to the degradation by the enzyme dipeptidyl peptidase IV (DPP-IV)

320 Wong, J

Allows you to switch providers during treatment

This change is expected to drive prices down, and open up access for millions of people

PMC 12476660

If you experience persistent night sweats, it is a sign that your dosage or meal timing may need adjustment by your healthcare provider to prevent nocturnal blood sugar dips